Based on these findings, human renin and human angiotensinogen double‐transgenic (RA‐tg) animals have been used for in vivo evaluation of renin inhibitors against hypertension and kidney dysfunction to reduce the dose of renin inhibitors and exclude the possibility of off‐target effects related to high doses 17, 18. The gene discussed is REN; the disease is Hypertension.